Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis.

Lubbers R, Sutherland JS, Goletti D, de Paus RA, van Moorsel CHM, Veltkamp M, Vestjens SMT, Bos WJW, Petrone L, Del Nonno F, Bajema IM, Dijkman K, Verreck FAW, Walzl G, Gelderman KA, Groeneveld GH, Geluk A, Ottenhoff THM, Joosten SA, Trouw LA.

Front Immunol. 2018 Oct 23;9:2427. doi: 10.3389/fimmu.2018.02427. eCollection 2018.

2.

Cross-laboratory evaluation of multiplex bead assays including independent common reference standards for immunological monitoring of observational and interventional human studies.

van Meijgaarden KE, Khatri B, Smith SG, Drittij AMFH, de Paus RA, Goeman JJ, Ho MM, Dockrell HM, McShane H, Joosten SA, Ottenhoff THM.

PLoS One. 2018 Sep 4;13(9):e0201205. doi: 10.1371/journal.pone.0201205. eCollection 2018.

3.

Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults.

Weinberger B, Haks MC, de Paus RA, Ottenhoff THM, Bauer T, Grubeck-Loebenstein B.

Front Immunol. 2018 May 15;9:1035. doi: 10.3389/fimmu.2018.01035. eCollection 2018.

4.

Immunological characterization of latent tuberculosis infection in a low endemic country.

de Paus RA, van Meijgaarden KE, Prins C, Kamphorst MH, Arend SM, Ottenhoff THM, Joosten SA.

Tuberculosis (Edinb). 2017 Sep;106:62-72. doi: 10.1016/j.tube.2017.07.001. Epub 2017 Jul 4.

PMID:
28802407
5.

Transduction of Herpesvirus saimiri-Transformed T Cells with Exogenous Genes of Interest.

Martínez-Barricarte R, de Jong SJ, Markle J, de Paus R, Boisson-Dupuis S, Bustamante J, van de Vosse E, Fleckenstein B, Casanova JL.

Curr Protoc Immunol. 2016 Nov 1;115:7.21C.1-7.21C.12. doi: 10.1002/cpim.15.

PMID:
27801513
6.

Differential expression and function of human IL-12Rβ2 polymorphic variants.

de Paus RA, Geilenkirchen MA, van Riet S, van Dissel JT, van de Vosse E.

Mol Immunol. 2013 Dec;56(4):380-9. doi: 10.1016/j.molimm.2013.07.002. Epub 2013 Aug 1.

PMID:
23911393
7.

IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database.

van de Vosse E, Haverkamp MH, Ramirez-Alejo N, Martinez-Gallo M, Blancas-Galicia L, Metin A, Garty BZ, Sun-Tan Ç, Broides A, de Paus RA, Keskin Ö, Çağdaş D, Tezcan I, Lopez-Ruzafa E, Aróstegui JI, Levy J, Espinosa-Rosales FJ, Sanal Ö, Santos-Argumedo L, Casanova JL, Boisson-Dupuis S, van Dissel JT, Bustamante J.

Hum Mutat. 2013 Oct;34(10):1329-39. doi: 10.1002/humu.22380. Epub 2013 Aug 8. Review.

8.

The influence of influenza virus infections on the development of tuberculosis.

de Paus RA, van Crevel R, van Beek R, Sahiratmadja E, Alisjahbana B, Marzuki S, Rimmelzwaan GF, van Dissel JT, Ottenhoff TH, van de Vosse E.

Tuberculosis (Edinb). 2013 May;93(3):338-42. doi: 10.1016/j.tube.2013.02.006. Epub 2013 Mar 7.

9.

Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β.

de Paus RA, van Wengen A, Schmidt I, Visser M, Verdegaal EM, van Dissel JT, van de Vosse E.

Cytokine. 2013 Feb;61(2):645-55. doi: 10.1016/j.cyto.2012.12.005. Epub 2013 Jan 5.

PMID:
23299081
10.

Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-γR2 deficiency.

Kilic SS, van Wengen A, de Paus RA, Celebi S, Meziane B, Hafizoglu D, van Dissel JT, van de Vosse E.

J Infect. 2012 Dec;65(6):568-72. doi: 10.1016/j.jinf.2012.08.008. Epub 2012 Aug 15.

PMID:
22902943
11.

Disseminated Mycobacterium genavense infection in a patient with a novel partial interleukin-12/23 receptor β1 deficiency.

Potjewijd J, de Paus RA, van Wengen A, Damoiseaux J, Verbon A, van de Vosse E.

Clin Immunol. 2012 Aug;144(2):83-6. doi: 10.1016/j.clim.2012.05.007. Epub 2012 May 24.

PMID:
22695533
12.

A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activation.

Mul D, Wu S, de Paus RA, Oostdijk W, Lankester AC, Duyvenvoorde HA, Ruivenkamp CA, Losekoot M, Tol MJ, De Luca F, van de Vosse E, Wit JM.

Eur J Endocrinol. 2012 Apr;166(4):743-52. doi: 10.1530/EJE-11-0774. Epub 2012 Jan 3.

PMID:
22214923
13.

Effect of amino acid substitutions in the human IFN-γR2 on IFN-γ responsiveness.

de Paus RA, Kilic SS, van Dissel JT, van de Vosse E.

Genes Immun. 2011 Mar;12(2):136-44. doi: 10.1038/gene.2010.74. Epub 2011 Jan 20.

PMID:
21248774
14.

Mycobacterium bovis BCG-itis and cervical lymphadenitis due to Salmonella enteritidis in a patient with complete interleukin-12/-23 receptor beta1 deficiency.

van de Vosse E, Ottenhoff TH, de Paus RA, Verhard EM, de Boer T, van Dissel JT, Kuijpers TW.

Infection. 2010 Apr;38(2):128-30. doi: 10.1007/s15010-009-9222-0. Epub 2010 Mar 5.

PMID:
20213287
15.

Salmonella induced IL-23 and IL-1beta allow for IL-12 production by monocytes and Mphi1 through induction of IFN-gamma in CD56 NK/NK-like T cells.

van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E.

PLoS One. 2009 Dec 21;4(12):e8396. doi: 10.1371/journal.pone.0008396.

16.

Functional analysis of naturally occurring amino acid substitutions in human IFN-gammaR1.

van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E.

Mol Immunol. 2010 Feb;47(5):1023-30. doi: 10.1016/j.molimm.2009.11.016. Epub 2009 Dec 16.

PMID:
20015550
17.

Antisense-mediated exon skipping to correct IL-12Rbeta1 deficiency in T cells.

van de Vosse E, Verhard EM, de Paus RA, Platenburg GJ, van Deutekom JC, Aartsma-Rus A, van Dissel JT.

Blood. 2009 May 7;113(19):4548-55. doi: 10.1182/blood-2008-12-196220. Epub 2009 Mar 3. Erratum in: Blood. 2009 Nov 12;114(20):4607.

PMID:
19258592
18.

IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.

van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E.

Int Immunol. 2009 Feb;21(2):145-53. doi: 10.1093/intimm/dxn132. Epub 2008 Dec 15.

PMID:
19088061
19.

Low level IGF-1 and common variable immune deficiency: an unusual combination.

van Bilsen K, Driessen GJ, de Paus RA, van de Vosse E, van Lom K, van Zelm MC, Lam KH, Hartwig NG, Baarsma GS, van de Burg M, van Hagen PM.

Neth J Med. 2008 Oct;66(9):368-72.

20.

IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants.

de Paus RA, van de Wetering D, van Dissel JT, van de Vosse E.

Mol Immunol. 2008 Sep;45(15):3889-95. doi: 10.1016/j.molimm.2008.06.029.

PMID:
18675459
21.

Molecular complementation of IL-12Rbeta1 deficiency reveals functional differences between IL-12Rbeta1 alleles including partial IL-12Rbeta1 deficiency.

van de Vosse E, de Paus RA, van Dissel JT, Ottenhoff TH.

Hum Mol Genet. 2005 Dec 15;14(24):3847-55. Epub 2005 Nov 17.

PMID:
16293671
22.

HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.

van der Veken LT, Hoogeboom M, de Paus RA, Willemze R, Falkenburg JH, Heemskerk MH.

Gene Ther. 2005 Dec;12(23):1686-95.

PMID:
16034453
23.

The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.

Zoet YM, Eijsink C, Kardol MJ, Franke-van Dijk ME, Wilson GL, de Paus R, Mickelson E, Heemskerk M, van den Elsen PJ, Claas FH, Mulder A, Doxiadis II.

Hum Immunol. 2005 May;66(5):519-25. Epub 2005 Feb 12.

PMID:
15935889
24.

Proteosomal degradation of BCR/ABL protein can generate an HLA-A*0301-restricted peptide, but high-avidity T cells recognizing this leukemia-specific antigen were not demonstrated.

Posthuma EF, van Bergen CA, Kester MG, de Paus RA, van Veelen PA, de Ru AH, Drijfhout JW, Lurvink EG, Willemze R, Falkenburg JH.

Haematologica. 2004 Sep;89(9):1062-71.

25.

Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.

Heemskerk MH, Hoogeboom M, de Paus RA, Kester MG, van der Hoorn MA, Goulmy E, Willemze R, Falkenburg JH.

Blood. 2003 Nov 15;102(10):3530-40. Epub 2003 Jul 17.

PMID:
12869497
26.

Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.

Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA, Heemskerk MH, Löwik CW, Falkenburg JH, Willemze R, Fibbe WE.

Exp Hematol. 2002 Aug;30(8):870-8.

PMID:
12160838
27.

Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.

Heemskerk MH, de Paus RA, Lurvink EG, Koning F, Mulder A, Willemze R, van Rood JJ, Falkenburg JH.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6806-11. Epub 2001 May 29.

29.

DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection.

Vogt MH, de Paus RA, Voogt PJ, Willemze R, Falkenburg JH.

Blood. 2000 Feb 1;95(3):1100-5.

PMID:
10648428
30.

Sensitive mRNA detection by fluorescence in situ hybridization using horseradish peroxidase-labeled oligodeoxynucleotides and tyramide signal amplification.

van de Corput MP, Dirks RW, van Gijlswijk RP, van Binnendijk E, Hattinger CM, de Paus RA, Landegent JE, Raap AK.

J Histochem Cytochem. 1998 Nov;46(11):1249-59.

PMID:
9774624
31.

Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells.

Smit WM, Rijnbeek M, van Bergen CA, de Paus RA, Vervenne HA, van de Keur M, Willemze R, Falkenburg JH.

Hum Immunol. 1997 Apr 1;53(2):216-23.

PMID:
9129981
32.

Human cytotoxic CD8+ T-lymphocyte clones engraft in severe combined immunodeficient (SCID) mice but show diminished function.

de Kroon JF, van Bergen CA, de Paus RA, Kluin-Nelemans HC, Willemze R, Falkenburg JH.

J Immunother. 1997 Mar;20(2):101-10.

PMID:
9087382
33.

Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.

de Kroon JF, de Paus RA, Kluin-Nelemans HC, Kluin PM, van Bergen CA, Munro AJ, Hale G, Willemze R, Falkenburg JH.

Exp Hematol. 1996 Jul;24(8):919-26.

PMID:
8690051
34.

Differential transcriptional and posttranscriptional regulation of gene expression of the colony-stimulating factors by interleukin-1 and fetal bovine serum in murine fibroblasts.

Falkenburg JH, Harrington MA, de Paus RA, Walsh WK, Daub R, Landegent JE, Broxmeyer HE.

Blood. 1991 Aug 1;78(3):658-65.

PMID:
1713511
35.

Effects of FSH and IGF-I on immature rat Sertoli cells: inhibin alpha- and beta-subunit mRNA levels and inhibin secretion.

Toebosch AM, Robertson DM, Trapman J, Klaassen P, de Paus RA, de Jong FH, Grootegoed JA.

Mol Cell Endocrinol. 1988 Jan;55(1):101-5.

PMID:
3129322

Supplemental Content

Loading ...
Support Center